Cryo-Cell International, Inc. (CCEL) earnings
CCEL earnings moved a median of +0.10% by the close. Quarterly and annual CCEL reports and results, each read against the price at its own news timestamp. Back to the CCEL overview →
22 measured CCEL earnings events.
Where these CCEL earnings landedvs 22 measured CCEL earnings reactions
| Middle 50% of CCEL earnings reactions | -4.29% to +1.06% |
|---|---|
| Median reaction (to close) | +0.10% |
| Measured reactions | 22 |
Point-in-time · zero look-ahead
Half of the 22 CCEL earnings events with a measured close landed between -4.29% and +1.06%; 50% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2026 Financial Results | Press release | -0.35% | -5.26% | |
| Form 10-Q CRYO CELL INTERNATIONAL For: Aug 31 | SEC filing · Form 10-Q | -0.35% | -5.26% | |
| Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2026 Financial Results | Press release | +3.82% | +2.35% | |
| Form 10-Q CRYO CELL INTERNATIONAL For: May 31 | SEC filing · Form 10-Q | +3.82% | +2.35% | |
| Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2026 Financial Results | Press release | +0.00% | +8.80% | |
| Form 10-Q CRYO CELL INTERNATIONAL For: Feb 28 | SEC filing · Form 10-Q | +0.00% | +8.80% | |
| Form 10-K CRYO CELL INTERNATIONAL For: Nov 30 | SEC filing · Form 10-K | +0.00% | +0.92% | |
| Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2025 Financial Results | Press release | — | -1.10% | |
| Form 10-Q CRYO CELL INTERNATIONAL For: Aug 31 | SEC filing · Form 10-Q | — | -1.10% | |
| Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2025 Financial Results | Press release | — | +0.20% | |
| Form 10-Q CRYO CELL INTERNATIONAL For: May 31 | SEC filing · Form 10-Q | — | +0.20% | |
| Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2025 Financial Results | Press release | +0.55% | +1.06% | |
| Form 10-Q CRYO CELL INTERNATIONAL For: Feb 28 | SEC filing · Form 10-Q | +0.55% | +1.06% | |
| Form 10-K CRYO CELL INTERNATIONAL For: Nov 30 | SEC filing · Form 10-K | -2.66% | -14.94% | |
| Form 10-Q/A CRYO CELL INTERNATIONAL For: Aug 31 | SEC filing · Form 10-Q | -0.16% | +2.48% | |
| Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2024 Financial Results | Press release | +0.00% | +0.00% | |
| Form 10-Q CRYO CELL INTERNATIONAL For: Aug 31 | SEC filing · Form 10-Q | +0.00% | +0.00% | |
| Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2024 Financial Results | Press release | +0.00% | -5.53% | |
| Form 10-Q CRYO CELL INTERNATIONAL For: May 31 | SEC filing · Form 10-Q | +0.00% | -5.53% | |
| Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2024 Financial Results | Press release | +0.24% | -4.29% | |
| Form 10-Q CRYO CELL INTERNATIONAL For: Feb 29 | SEC filing · Form 10-Q | +0.24% | -4.29% | |
| Form 10-K CRYO CELL INTERNATIONAL For: Nov 30 | SEC filing · Form 10-K | — | +0.78% |
Keep exploring
More CCEL: analyst actions → · SEC filings → · CCEL overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| SWEDISH ORPHAN ADR (SWTUY) | 86 | 0.00% | 8% |
| BIOLASE INC (BIOL) | 85 | -2.09% | 28% |
| Kane Biotech Inc (KNE_CDNX) | 85 | 0.00% | 22% |
| Regen Biopharma, Inc. Common (RGBP) | 85 | 0.00% | 36% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.